(Philadelphia,
PA) - Ellen J. Kim, MD, has been named Assistant
Professor, Clinician-Educator Track, in the Department
of Dermatology at University of Pennsylvania School
of Medicine.
Dr. Kim began her academic career at Harvard University,
where she earned an AB degree (magna cum laude) in East
Asian Studies. She furthered her education at the University
of Pennsylvania, where she earned her MD in 1996. She
performed her residency at Boston University/Tufts University
and research fellowship with the Department of Dermatology
at Boston University's School of Medicine. Dr. Kim was
also a research scholar in the Howard Hughes Medical
Institute Cloisters Program in Bethesda, Maryland. She
is currently an Attending Physician of the Photopheresis
Service unit and the Cutaneous Lymphoma Clinic at the
Hospital of the University of Pennsylvania.
Her research focuses on novel treatments for cutaneous
T-cell lymphoma. Her research has been published in
the Journal of Immunology and she has contributed to
the peer-reviewed clinical publications Clinical
Nuclear Medicine, the Journal of the American
Academy of Dermatology and the Archives of Dermatology.
Dr. Kim has received many accolades including admission
to Phi Beta Kappa from Harvard University, the 2002
Boston University/Tufts University Dermatology Training
Program Teacher of the Year Award, the 2000-2002 Dermatology
Foundation Research Fellowship Award and the 2001 Mentor
Recognition Award from the Siemens Westinghouse Science
& Technology Competition.
# # #
.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.